Healthcare -
Biotechnology - NASDAQ - US
$ 8.03
-0.623 %
$ 178 M
Market Cap
-3.68
P/E
INMB - CASH FROM OPERATIONS
Cash from Operations INMB - INmune Bio, Inc.
-12 M
LAST VALUE
35.17%
2 YEAR CAGR
-42.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR